Tourmaline Bio (TRML) has a host of catalysts for investors to look forward to in 2025, which sets up the ability for it to generate substantial shareholder value. One of the main programs for its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback